Business
China considering mixing COVID-19 vaccines to boost ‘low effectiveness’ – The Age
China’s top disease control official has said the country is formally considering mixing COVID-19 vaccines, as a way of further boosting vaccine efficacy.
Experts say mixing vaccines, or sequential immunisation, might boost effectiveness. Researchers in Britain are studying a possible combination of Pfizer-BioNTech and the traditional AstraZeneca vaccine.
The coronavirus pandemic, which began in central China in late 2019, marks the first time the Chinese drug industry has played a role in responding to a global health emergency.
Vaccines made by Sinovac, a private company, and Sinopharm, a state-owned firm, have made up the majority of Chinese vaccines…
-
Noosa News17 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business22 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General23 hours agoRush to buy homes before rate cuts send prices soaring
-
Business20 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025